Medical AI Alliance
← Company Index
Medical DevicesKOSDAQ 1537108 approvals

Optipharm.CO.,LTD

Official website

Optipharm, founded in 2000 and KOSDAQ-listed in 2018, provides animal disease diagnostics, animal medicine, and biotech.

As of 2026-10-10, Optipharm.CO.,LTD has 8 Korean MFDS device approvals, 94 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

Founded in 2000 and listed on KOSDAQ in 2018, Optipharm specializes in animal disease diagnostics, animal medicine, and biotechnology. It operates animal disease diagnostic services using serological, antigen gene (PCR), and histopathological testing, along with molecular diagnostic kits for diseases including African swine fever, porcine reproductive and respiratory syndrome (PRRS), and avian influenza, plus animal medicine distribution, bacteriophage development, the Medipig miniature pig and xenotransplantation business, and VLP vaccine development. It has been designated by the Animal and Plant Quarantine Agency for 84 diseases and 212 test items, transferred a PRRS preventive vaccine strain license in April 2020, and obtained item approval for the swine oral fluid collection kit after registering as an animal medical device manufacturer in August 2019.

Regulatory approvals

data.go.kr

8 Korean MFDS device approvals · 2013–2024

  • MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2024-09-30
    Product approval · Class 3체외 제허 24-657 호
  • MFDSIVD reagents for cancer related gene2018-03-29
    Product approval · Class 3체외 제허 18-212 호
  • MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2018-01-31
    Product approval · Class 3체외 제허 18-56 호
  • MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2017-05-19
    Product approval · Class 3체외 제허 17-333 호
  • MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2017-05-19
    Product approval · Class 3체외 제허 17-332 호
  • MFDSIVD reagents for staining or culturing clinical microbiologyRevoked2015-05-19
    Product approval · Class 1대전 체외 제신 15-47 호
  • MFDSIVD reagents for staining or culturing clinical microbiologyRevoked2015-05-19
    Product approval · Class 1대전 체외 제신 15-46 호
  • MFDSIVD reagents for extracting nucleic acids2013-07-08
    Product approval · Class 1대전 체외 제신 13-44 호

Key disclosures

KRX KIND via OpenDART

Publications

PubMed · affiliation-matched
Show 84 more publications

Patents

KIPRIS · applicant-matched
Show 132 more patents

AI reads

MAA server logs · IP-verified
77
Times AI engines pulled Optipharm.CO.,LTD's records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

0
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

77
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

9
live 0
Last 7 days
64
live 0
Last 30 days
77
live 0
All time
  • OpenAIOAI-SearchBot56
  • PerplexityPerplexityBot9
  • GoogleGoogleOther9
  • AnthropicClaudeBot2
  • MicrosoftBingbot1

Measured since Aug 27, 2026 · 5 AI engines · last read Oct 9, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for Optipharm.CO.,LTD and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview · products · R&D. Send us materials and we will add them

Companies approved for the same productsMedical Devices

Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.

GC Medical Science Corporation4 shared

GC Medical Science Corporation, KOSDAQ-listed since 2014, operates diagnostic reagent, blood glucose, and hemodialysis solution businesses.

Gencurix Inc.3 shared

Founded 2011, KOSDAQ-listed 2020, Gencurix develops liquid-biopsy diagnostics: breast cancer prognosis and lung/colorectal companion tests.

BIONEERCORPORATION3 shared

Bioneer, founded in 1992 and KOSDAQ-listed in 2005, provides gene analysis equipment, molecular diagnostics, and RNAi drug development.

HLB PANAGENE Co., LTD.3 shared

Founded in 1976 and KOSDAQ-listed in 2000, HLB PANAGENE develops PNA-based molecular diagnostic and diagnostic automation products.

LabGenomics. Co., Ltd.3 shared

KOSDAQ-listed molecular genetic diagnostics company providing NGS-based non-invasive prenatal testing (NIPT) under the MomGuard brand.

SEEGENE, INC.3 shared

Founded in 2000 and KOSDAQ-listed in 2010, Seegene develops syndromic multiplex PCR molecular diagnostic reagents.

Genomictree Inc.3 shared

Cancer molecular diagnostics company behind the EarlyTect-C stool-based colorectal cancer test using the SDC2 methylation biomarker.

NanoenTek,Inc.2 shared

Founded in 1987 and listed on KOSDAQ in 2000, NanoenTek develops Lab-On-a-Chip in-vitro diagnostic devices and life science instruments.

GENOLUTION INC.2 shared

Founded in 2006 and listed on KOSDAQ in 2020, Genolution is a molecular diagnostics and RNAi company producing nucleic acid extraction reagents and devices.

OSANG HEALTHCARE CO.,LTD.2 shared

Founded 1996, listed on KOSDAQ in 2024, OSANG HEALTHCARE develops and sells biochemistry, immunodiagnostic, and molecular IVD products.

PCL. Inc2 shared

KOSDAQ-listed IVD company using SG Cap™ multiplex diagnostic technology for infectious disease, cancer, and companion animal testing.

CALTH. Inc2 shared

Holds manufacturing approvals for 42 point-of-care diagnostic reagents and devices in the IVD market.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition